BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20887570)

  • 1. Stepping through treatment: reflections on an adaptive treatment strategy among methamphetamine users with depression.
    Kay-Lambkin FJ; Baker AL; McKetin R; Lee N
    Drug Alcohol Rev; 2010 Sep; 29(5):475-82. PubMed ID: 20887570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy.
    Kay-Lambkin FJ; Baker AL; Lewin TJ; Carr VJ
    Addiction; 2009 Mar; 104(3):378-88. PubMed ID: 19207345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction.
    Baker A; Lee NK; Claire M; Lewin TJ; Grant T; Pohlman S; Saunders JB; Kay-Lambkin F; Constable P; Jenner L; Carr VJ
    Addiction; 2005 Mar; 100(3):367-78. PubMed ID: 15733250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Psychostimulant Check-Up: A pilot study of a brief intervention to reduce illicit stimulant use.
    Smout MF; Longo M; Harrison S; Minniti R; Cahill S; Wickes W; White JM
    Drug Alcohol Rev; 2010 Mar; 29(2):169-76. PubMed ID: 20447225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence.
    Kay-Lambkin FJ
    Drug Alcohol Rev; 2008 May; 27(3):318-25. PubMed ID: 18368614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of relapse in Filipino male methamphetamine users: a mixed methods approach.
    Tuliao AP; Liwag ME
    J Ethn Subst Abuse; 2011; 10(2):162-79. PubMed ID: 21678148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users.
    Hillhouse MP; Marinelli-Casey P; Gonzales R; Ang A; Rawson RA;
    Addiction; 2007 Apr; 102 Suppl 1():84-95. PubMed ID: 17493057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It's the thought that counts: craving metacognitions and their role in abstinence from methamphetamine use.
    Lee NK; Pohlman S; Baker A; Ferris J; Kay-Lambkin F
    J Subst Abuse Treat; 2010 Apr; 38(3):245-50. PubMed ID: 20116959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mindfulness-based cognitive therapy for treatment-resistant depression: a pilot study.
    Eisendrath SJ; Delucchi K; Bitner R; Fenimore P; Smit M; McLane M
    Psychother Psychosom; 2008; 77(5):319-20. PubMed ID: 18600038
    [No Abstract]   [Full Text] [Related]  

  • 12. Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.
    Hellem TL; Sung YH; Shi XF; Pett MA; Latendresse G; Morgan J; Huber RS; Kuykendall D; Lundberg KJ; Renshaw PF
    J Dual Diagn; 2015; 11(3-4):189-202. PubMed ID: 26457568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticolimbic dysregulation and chronic methamphetamine abuse.
    Baicy K; London ED
    Addiction; 2007 Apr; 102 Suppl 1():5-15. PubMed ID: 17493049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal methamphetamine use and antiretroviral drug resistance: a pilot study of behavioral and clinical correlates.
    Ghaziani A
    IAPAC Mon; 2005 Oct; 11(10):297-9. PubMed ID: 16673497
    [No Abstract]   [Full Text] [Related]  

  • 15. Methamphetamine use and dental disease: results of a pilot study.
    Cretzmeyer M; Walker J; Hall JA; Arndt S
    J Dent Child (Chic); 2007; 74(2):85-92. PubMed ID: 18477425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of psychosocial interventions for amphetamine use.
    Baker A; Lee NK
    Drug Alcohol Rev; 2003 Sep; 22(3):323-35. PubMed ID: 15385227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive profiles of people with comorbid depression and alcohol use: implications for psychological interventions.
    Hunt SA; Baker AL; Michie PT; Kavanagh DJ
    Addict Behav; 2009 Oct; 34(10):878-86. PubMed ID: 19398163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contingency management: schedule effects.
    Roll JM; Shoptaw S
    Psychiatry Res; 2006 Sep; 144(1):91-3. PubMed ID: 16905197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based treatments for methamphetamine abuse.
    Campos M; Shoptaw S
    Focus; 2005 Jul; 20(6):5-6. PubMed ID: 16110567
    [No Abstract]   [Full Text] [Related]  

  • 20. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program.
    Jaffe A; Shoptaw S; Stein J; Reback CJ; Rotheram-Fuller E
    Exp Clin Psychopharmacol; 2007 Jun; 15(3):301-7. PubMed ID: 17563217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.